Launching DTC models requires navigating regulatory and licensing rules.
Spreeha Choudhury, JD, PharmD
Advertisement
Articles by Spreeha Choudhury, JD, PharmD
The idea of denying people proven medicines in the name of research has a dark legacy in this country.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry
2
Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon
3
Pharmaceutical Executive Daily: FDA Approves Breztri
4
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
5